EGFR and glioblastoma: Dysregulation of the ErbB pathway has been reported to contribute to GBM progression [12], with mutation, rearrangement, altered splicing and/or focal amplification of the epidermal growth factor receptor (EGFR) gene observed in over half of GBM cases [13–15].